Loading clinical trials...
Loading clinical trials...
This study is a randomized, open-label, active comparator-controlled, dose-ranging trial of the efficacy and safety of IV artesunate in combination with IV GCV or oral VGCV and SOC treatment compared ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Amivas Inc.
NCT03798301 · CMV Infection, Cytomegalovirus Infections, and more
NCT06362720 · CMV Infection or Reactivation After Allogenic HSCT
NCT02680743 · Congenital CMV Infection
NCT06021210 · CMV Infection, Hematopoietic Stem Cell Transplantation
NCT05914675 · The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
Westmead Hospital
Westmead
Princess Alexandra Hospital
Woolloongabba
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions